ArticleBMC pediatrics2025
SARS-CoV-2 infection in pregnancy and infant outcomes in the first year of life: a retrospective cohort study.
Article in BMC pediatrics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
backgroundThere are known maternal and obstetrical risks following SARS-CoV-2 infection in pregnancy, but the impact on offspring is not well known. The objective of this study was to examine offspring risks of hospitalization and emergency department visits in the first year of life following SARS-CoV-2 infection in pregnancy.
methodsThis was a retrospective cohort study in Ontario, Canada of infants born from March 1, 2020 to December 31, 2021 using health administrative databases. The exposure group was defined by a positive SARS-CoV-2 PCR test in pregnancy, while the comparator group included pregnancies without a positive test recorded. The primary outcomes included all-cause offspring hospitalizations and emergency department (ED) visits in the first year of life. Poisson regression was used to adjust for maternal sociodemographic factors, medical and obstetrical history, and health behaviours. The main secondary outcome was risk of infections (including respiratory, gastrointestinal and otitis media infections) in the first year of life. A sensitivity analysis was conducted in which individuals with a negative SARS-CoV-2 test served as the comparator group.
resultsThere were 222,448 live births during the study period; following matching 45,958 pregnancies were included. Cases were matched on maternal age, geography, and last menstrual period date in a 10:1 ratio. The exposed group included 5,291 pregnancies and the comparator group included 40,667 pregnancies. There was no significant difference observed between groups in risk of hospitalization (aRR (95% CI): 1.10 (0.99-1.22)). Small increases in risk of both ED visits (aRR 1.12 (1.06-1.17)), and infections (aHR 1.16 (1.11-1.21) were observed in the exposed group. When the comparator group was limited to pregnancies with a negative SARS-CoV-2 test, there was no difference in risk of ED visits, but the increased risk of infections persisted.
conclusionsA positive SARS-CoV-2 test in pregnancy was not associated with an increased risk of hospitalization in the offspring's first year, which may be reassuring to parents and healthcare providers. However, there may be a small increased risk of offspring infections.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.